- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Curtis Lowery on Technology's Place in the Future of Healthcare
Curtis Lowery, MD, chair of the Department of Obstetrics and Gynecology at the University of Arkansas for Medical Sciences and director of the Center for Distance Health, discusses how technology will impact the future of healthcare.
Transcript
How important is technology in the future of healthcare? What sort of innovations do you see happening in the next few years?
I think technology is very important in providing quality care and driving down costs. One only needs to look at the banking industry [and] online purchases to see how this technology revolutionizes the system.
I think that healthcare is now poised to take advantage of technology as well. The payer system needs to be reformed.
And it is being reformed underneath our eyes right now. We’re moving away from a fee-for-service world into bundled care payments and ultimately upside downside global contracts that would be so called "value-based" healthcare not volume-based, where you get rewarded for value and not seeing high volumes of patients or doing procedures to patients.
As we begin to do that, the obvious solution to this is to use technology, video conferencing and also devices deployed on patients to help in out-patient management and supporting smaller facilities to help them provide quality care and deliver patients that maybe they would bebe uncomfortable without the support of a tertiary care system.
We’re beginning to do what’s called population health, or population management. As we move forward with this, you're going to see more and more use of technology increased to provide the structure to do that kind of new care.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
